Since the WHO classification is based on the histological findings of TET tumors and CD4+CD8+ double-positive T cells, previous studies on TETs mainly focused on CD4+CD8+ double-positive T cells, not CD4 and CD8 single-positive T cells. The gene discussed is CD4; the disease is thymic epithelial neoplasm.